Thomas von Rüden

Thomas von Rüden With single-minded determination , he applied his dual interests to optimize the business of directed evolution (Direvo). By Claudia Eberhard- Metzger In a German secondary school in Bingen-on-Rhine, back in the 1970s, Thomas von Rüden stood in front of the blackboard explaining protein biosynthesis to the rest of the class. His teacher gave him 15 points, the best possible score, for his presentation, w

Written byClaudia Eberhard-Metzger
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

By Claudia Eberhard- Metzger

In a German secondary school in Bingen-on-Rhine, back in the 1970s, Thomas von Rüden stood in front of the blackboard explaining protein biosynthesis to the rest of the class. His teacher gave him 15 points, the best possible score, for his presentation, which revealed his fascination with molecular biology from an early stage. "That was just the kind of thing I wanted to do," he recalls. Though his father advised against it, young Thomas was determined to study biology, definitely not economics, the career his father had mapped out for him. "I can always go into management after university," he decided.

Pride and Pioneers

Solutions for megatrends

The Biocampus Cologne

It started with a kit

Two sides of a coin

Bluesens

Rainer Christine

Dortmund

Walk on the white side

The University of Duisburgessen

Come Together

Protein Research Department at the Ruhr University Bochum (RUB)

Alfred Oberholz

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies